Tetratherix (ASX:TTX) Current Accrued Expense: A$0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:TTX Tetratherix Ltd ASX:TTX
5 GF Score
Price A$7.13
! 3 Warning Signs
View Full Analysis

What is Tetratherix Current Accrued Expense?

Tetratherix ASX:TTX +0.78% 5 Current Accrued Expense is A$0.00 Mil as of Jun. 2026. GuruFocus rates ASX:TTX with a GF Score™ of 5/100. The stock has 3 warning signs investors should review.

Tetratherix's Current Accrued Expense for the quarter that ended in Jun. 2026 was A$0.00 Mil.

Tetratherix Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Tetratherix's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tetratherix Current Accrued Expense Chart

Tetratherix Annual Data
Trend Jun23 Jun24 Jun25 Jun26
Current Accrued Expense
0.00 0.00 0.00 0.00

Tetratherix Semi-Annual Data
Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Current Accrued Expense Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
ASX:TTX
5GF Score
Tetratherix Ltd ASX:TTX
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tetratherix Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of A$0.00 Mil mean?
Tetratherix (ASX:TTX) has a Current Accrued Expense of A$0.00 Mil as of Jun. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on Tetratherix and its competitors.
Is Tetratherix's Current Accrued Expense too high?
Tetratherix's current Current Accrued Expense is A$0.00 Mil. Overall, Tetratherix has a GF Score™ of 5/100, reflecting its overall financial health beyond just this single metric.
How does Tetratherix's Current Accrued Expense compare to VRTX and REGN?
Tetratherix's Current Accrued Expense of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Biotechnology company?
A good Current Accrued Expense depends on the Biotechnology industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Tetratherix and its competitors. Tetratherix's current Current Accrued Expense is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tetratherix stock overvalued right now?
Tetratherix (ASX:TTX) has a current Current Accrued Expense of A$0.00 Mil. The current Current Accrued Expense is A$0.00 Mil. Tetratherix's overall GF Score™ is 5/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Tetratherix (ASX:TTX), the current Current Accrued Expense is A$0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tetratherix Business Description

Address 34-36 Ralph Street, Unit 29, Alexandria, Sydney, NSW, AUS, 2015
Tetratherix Ltd is a biomedical company that has developed an biomaterial platform called Tetramatrix, a proprietary fluid matrix that induces minimal foreign body reaction. The principal activities include development programs in the areas of regenerative medicine and commercialising medical device technology across multiple applications including Bone Regeneration, Tissue Spacing and Tissue Healing.
5GF Score

Get the complete analysis for ASX:TTX

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$7.13
Price